All In Biotech

Drug Trial Radar · NCT02486055

A Safety Study of Orally Administered BPM31510 in Healthy Subjects

A Phase I Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of Orally Administered BPM 31510 in Healthy Subjects

Last checked: Nov 19, 2026Latest source record: Dec 22, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

20

Actual

Start

Nov 2015

Primary completion

Jan 2016

Study completion Jan 2016

Sponsor

Lead sponsor
BPGbioIndustry
Sponsor type
Industry
First posted
Jul 1, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Basic science
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is an open-label, Phase I study of the bioavailability and safety of BPM31510 in healthy subjects dosed 2 or 3 times daily for 4 days, after an initial cohort of 6 subjects receiving a single dose (pre-study cohort). The pre-study cohort subjects will receive 1600 mg as a single administration. Cohort 1 and Cohort 2 will consist of 10 patients each. The cohorts may be enrolled sequentially.

Conditions

  • Healthy

Interventions

  • BPM31510 Oral Nanosuspension 4%Drug

    Oral nanosuspension formulation of BPM31510 (ubidecarenone, USP)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. CmaxTime frame: Days 1, 2, 8, and 15; baseline pre-dosing concentrations

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Clinilabs, Inc.

    Eatontown, New Jersey

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.